SCHEMBL13859233

SCHEMBL13859233

C[C@]1(c2ccc(F)c([N+](=O)[O-])c2)OC(N)=NCC1(F)F

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.43
LMNA P02545 4/20 0.43
HTT P42858 3/20 0.43
ALDH1A1 P00352 3/20 0.41
HIF1A Q16665 1/20 0.41
VCAM1 P19320 1/20 0.37
ESPL1 Q14674 1/20 0.36
CYP1A2 P05177 2/20 0.35
CYP2C19 P33261 2/20 0.35
CYP2C9 P11712 1/20 0.35
NQO1 P15559 1/20 0.33
MITF O75030 1/20 0.33
GAA P10253 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
SMN1; SMN2 Q16637 2/20 0.33
HCRTR1 O43613 1/20 0.33
CYP2D6 P10635 1/20 0.33
TSHR P16473 1/20 0.32
BACE2 Q9Y5Z0 2/20 0.31
BACE1 P56817 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1979221 0.81 BACE2 (0.44) MAPTLMNAHTTALDH1A1HIF1A
SCHEMBL14165303 0.81 BACE2 (0.44) MAPTLMNAHTTALDH1A1HIF1A
SCHEMBL13859149 0.78 MAPK1 (0.33) MAPTLMNAHTTALDH1A1HIF1A
SCHEMBL13859030 0.77 SMN1; SMN2 (0.33) MAPTLMNAHTTALDH1A1CYP1A2
SCHEMBL1979176 0.76 BACE2 (0.33) MAPTHTTCYP2D6BACE2BACE1
SCHEMBL13836514 0.75 LMNA (0.53) MAPTLMNAHTTBACE2BACE1
SCHEMBL13836515 0.75 LMNA (0.53) MAPTLMNAHTTBACE2BACE1
SCHEMBL13278685 0.74 BACE2 (0.44) MAPTLMNAHTTALDH1A1HIF1A
SCHEMBL1980524 0.73 NPY5R (0.33) ALDH1A1CYP2D6NPY5R
SCHEMBL1979567 0.73 BACE2 (0.42) MAPTLMNAHTTALDH1A1VCAM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2709992-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. Hoffmann-La Roche AG (CH) 2014-03-26 EP disclosed
WO-2012156284-A1 1,3-OXAZINES AS BACE1 AND/OR BACE2 INHIBITORS F. HOFFMANN-LA ROCHE AG (CH) 2012-11-22 WO disclosed